• Tylerdurdon@lemmy.world
    link
    fedilink
    English
    arrow-up
    29
    ·
    1 year ago

    From what I saw elsewhere, the cost of the CRISPR treatment is roughly 2 million dollars and another way to implement the cure is via a modified flu virus. That version is roughly 3 million.

    • halcyoncmdr@lemmy.world
      link
      fedilink
      English
      arrow-up
      61
      arrow-down
      3
      ·
      1 year ago

      If only we knew what the real costs of treatment are, not the bullshit prices the industry decides they’ll say it is and then negotiate a barely more realistic real cost with insurance companies.

      Guess we’ll have to wait until this is approved in other countries for a real answer.

      • TheMurphy@lemmy.world
        link
        fedilink
        English
        arrow-up
        30
        arrow-down
        5
        ·
        1 year ago

        Guess we’ll have to wait until this is approved in other countries for a real answer.

        Hard to know the price in other countries when it’s free, eh?

        • krellor@kbin.social
          link
          fedilink
          arrow-up
          34
          ·
          1 year ago

          Just because they don’t issue a bill doesn’t mean they don’t track costs. They track labor, labor rates, and consumables.

          That said, this particular treatment is very involved. They harvest cells over multiple periods, send them to a lab to be modified, and when they are ready they do chemotherapy to kill your immune system, then do a bone marrow transplant to introduce the modified cells, and then you have to be in isolation in a hospital until your immune system comes back. Even the best facilities are saying they can only do 5-10 of these per year.

          Pretty crazy.

      • j4yt33@feddit.de
        link
        fedilink
        English
        arrow-up
        8
        arrow-down
        2
        ·
        1 year ago

        It’s tricky because the money, time and opportunity cost gone into development, testing and the approval process are also priced into this. Plus the fact that this needs to not only break even but make some money plus the fact that this won’t be relevant for a huge market I think (not sure how prevalent SCD is). So it’s an outrageous price but probably not just plucked out of thin air

        • Dave@lemmy.world
          link
          fedilink
          English
          arrow-up
          21
          ·
          1 year ago

          This is why pharma research should be publicly funded, and the results go directly into public domain. We will save so much money and lives in the long run that way.

          • halcyoncmdr@lemmy.world
            link
            fedilink
            English
            arrow-up
            30
            ·
            1 year ago

            A LOT of pharma research gets significant public funding. They then patent it and privatize the profits. Then spending millions on advertising.

            Then they try and justify pricing from the total cost of not only development, but also advertising budgets, while avoiding any mention of where the actual development funding came from in the first place.

            That’s not for everything, but it’s a large enough number of drugs and treatments that the entire industry is based on bullshit.

          • cynar@lemmy.world
            link
            fedilink
            English
            arrow-up
            10
            ·
            1 year ago

            The bigger one is to decouple development from manufacturing.

            Development should be done on a bounty type system. Both countries and individual groups can put money into bounties.

            Once the bounty is claimed, then the drug is effectively free for all to produce. This lets us leverage capitalism to push prices down.

            This would reshape drug development from max money, to most needed.

            • mapiki@lemm.ee
              link
              fedilink
              English
              arrow-up
              1
              ·
              1 year ago

              I like this - but would companies that fail (in being second) not get credit for their work? You could imagine the second place actually having a more effective product at the end.

              • cynar@lemmy.world
                link
                fedilink
                English
                arrow-up
                1
                ·
                1 year ago

                You don’t have a yes/no payout. You have a graded payout. E.g. you might have a 1 shot cure pay out the full amount, but a sustained treatment only pay a smaller %. This lets you encourage development of the most effective treatment, not the most profitable. It’s currently better to make a condition chronic, and so need treatment for a lifetime, than develop a cure.

                You also don’t pay out all at once. By spreading it out over sat 10 years. It means it can be adjusted if the company’s claims are… less than accurate.

        • RatherBeMTB@sh.itjust.works
          link
          fedilink
          English
          arrow-up
          5
          arrow-down
          18
          ·
          1 year ago

          That’s bullshit! The most advanced technology ever developed by mankind and the most expensive to develop is AI. And I can pay Open AI 20 bucks a month to hire what is basically a human in the 10th too percentile for 20 bucks.

          The only difference is the elasticity of the market. If I need your fucking drug and you have a patent then I will have to give you all I have so I don’t die.

          The healthcare system in the US is just fucked up.

  • set_secret@lemmy.world
    link
    fedilink
    English
    arrow-up
    16
    ·
    1 year ago

    wow this is huge for anyone with sickle cell that lives in a country that has universal healthcare. Other countries I guess it’s great for super rich people.

  • ThoGot@lemm.ee
    link
    fedilink
    English
    arrow-up
    4
    ·
    1 year ago

    I’m wondering how such a treatment will be handled in countries with a high malaria prevalence

    • SCB@lemmy.world
      link
      fedilink
      English
      arrow-up
      20
      arrow-down
      2
      ·
      edit-2
      1 year ago

      Emergent tech always starts out very expensive.

      Consider that the phone you probably posted this on is significantly more powerful than the first computers, which were several orders of magnitude larger and more expensive.

      • chitak166@lemmy.world
        link
        fedilink
        English
        arrow-up
        4
        arrow-down
        3
        ·
        1 year ago

        Yeah, great points. Economies of scale have not kicked in, and I’m sure there are plenty of inefficiencies with the technologies they’re currently using.

        • OwlBoy@lemmy.world
          link
          fedilink
          English
          arrow-up
          3
          ·
          1 year ago

          It would be neat to know precisely what parts are expensive. Broad generalizations about how prices on goods go up and down aren’t quite as interesting. 😅

  • AutoTL;DR@lemmings.worldB
    link
    fedilink
    English
    arrow-up
    3
    ·
    1 year ago

    This is the best summary I could come up with:


    The Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease, a devastating illness that affects more than 100,000 Americans, the majority of whom are Black.

    In April 2021, Morning joined the clinical trial at Sarah Cannon Research Institute and HCA Healthcare’s The Children’s Hospital at TriStar Centennial in Nashville, Tennessee, a decision she initially regretted.

    Dr. Haydar Frangoul, medical director of pediatric hematology-oncology for the Sarah Cannon Research Institute, said he is hopeful the therapy will provide relief to more patients.

    Dr. Nicole Verdun, director of the Office of Therapeutic Products in the FDA’s Center for Biologics Evaluation and Research, said Lyfgenia was given the warning after two patients who got the therapy in a clinical trial died from a form of leukemia.

    It’s unclear whether the gene therapy itself or another part of the treatment process, such as the chemotherapy, caused the cancer, but Verdun said the agency thought the deaths “rose to the level of a black-box warning.”

    Christopher Vega, 31, from Allentown, Pennsylvania, said the possibility of long-term effects aren’t a concern for him; he is happy to be living a life free of chronic pain.


    The original article contains 1,565 words, the summary contains 194 words. Saved 88%. I’m a bot and I’m open source!

    • TheMurphy@lemmy.world
      link
      fedilink
      English
      arrow-up
      7
      arrow-down
      16
      ·
      1 year ago

      Alright real question here. I’ve noticed after I came on reddit and Lemmy, something I believe I’ve only seen in American media.

      Why is it so important to mention people’s skin colour all the time? This affects 100.000 Americans, and then they mention most are black?!

      Why does that matter? I can’t figure out why on earth they want to divide people up in race like that, like they are a different people. A different kind of Americans.

      It’s not hard to figure out why Americans are so divided, if they get talked about like a different group of people based on skin colour.

      • Ian@Cambio@lemm.ee
        link
        fedilink
        English
        arrow-up
        18
        arrow-down
        1
        ·
        1 year ago

        Because being black isn’t just a skin color. It also includes a genetic predisposition to this disease.

      • TheBananaKing@lemmy.world
        link
        fedilink
        English
        arrow-up
        7
        arrow-down
        1
        ·
        1 year ago

        For one, it’s a genetic disorder that’s linked to ancestry.

        For another, there’s a huge social-justice issue around race in the US. Black people are hugely overrepresented in prisons, and there are vast, ingrained and systemic prejudices and barriers to equality everywhere you look.

        This is why ferinstance efforts to enforce photo-ID requirements for voting would significantly disenfranchise Black voters (which is the real reason conservatives keep trying to push for it), because a disproportionate percentage of Black people simply don’t have the means to obtain such ID - vastly more than the number of white people in a similar position.

        Take centuries of explicitly racist law and policy directly excluding and oppressing Black people. Wind back the explicit racism over the last handful of decades, but quietly replace it with exclusion and oppression based on the socieconomic disparity thus created. Now you can claim to have a colourblind legal/etc system, yet continue to preserve and promote disadvantage that ends up depending on race.

        And because social mobility is an absolute joke over there (as it is in most places, tbh), then the opportunities and resources available to you will depend heavily and primarily on the opportunities and resources available to your family and community for many generations back. There’s not just generational wealth to deal with, but generational influence and networking; you can’t be in with the Right People unless your parents were, and neither could they, rinse and repeat. And when the Right People instantly dismiss you on sight, or even just by seeing your name, then you’re fucked.

        So when someone says that a hundred thousand people in the US have a crippling and debilitating disease, and the great majority are Black - yeah, it means something. It means that a chunk of the population are getting a raw deal on top of the shit sandwich they’ve been handed just by being born, and that this is just one more thing that, for the most part, white people don’t have to care about. And because the fucked up healthcare system in the US is so profit-driven, that means there’s going to be vastly less done about it than if it were equally spread across demographics.

        • jasory@programming.dev
          link
          fedilink
          English
          arrow-up
          1
          arrow-down
          4
          ·
          1 year ago

          “simply don’t have the means to obtain ID”

          It can be “disproportionate” and still miniscule. The reality is that the group supposedly being suppressed already has an extremely low turn out rate (non-ID holders aren’t necessarily strongly socially let alone politically active). There have been multiple studies that show that this has very little effect.

          “Voter Fraud” and “suppression” are an interesting case where both sides have been peddling unfounded conspiracies about each other.